Volume 24, Number 12—December 2018
Research
CTX-M-65 Extended-Spectrum β-Lactamase–Producing Salmonella enterica Serotype Infantis, United States1
Table 2
Characteristics of patients and 5 Salmonella enterica serotype Infantis pattern JFXX01.0787 isolates without CTX-M-65, United States*
Accession no.† | Year | Specimen source | Resistance profile | Plasmids | gyrA | parC | Hospitalized | Recent travel |
---|---|---|---|---|---|---|---|---|
SRR2485280 |
2012 |
Feces |
No resistance detected |
No replicons detected |
None |
Wt |
No |
No travel |
SRR4025941 |
2012 |
Feces |
CSuTCip(I)NalCotGen(I) |
IncFIB-like |
D87Y |
Wt |
No |
Peru, Bolivia, Ecuador, Chile |
SRR4019596 |
2014 |
Urine |
CSSuTFox(I)Cip(I)NalCot |
IncFIB-like |
D87Y |
Wt |
No |
No data |
SRR3185042 |
2014 |
Feces |
No resistance detected |
No replicons detected |
None |
Wt |
Yes |
No travel |
SRR2485289 | 2015 | Feces | No resistance detected | No replicons detected | None | Wt | No | No data |
*A, ampicillin; Aug, amoxicillin-clavulanic acid; C, chloramphenicol; Cip, ciprofloxacin; Cot, trimethoprim/sulfamethoxazole; Cx, ceftriaxone; Fox, cefoxitin; Gen, gentamicin; (I), intermediate susceptibility; Nal, nalidixic acid; S, streptomycin; Su, sulfisoxazole; T, tetracycline; Tio, ceftiofur.
†Accession numbers are the sequence read archive run identification numbers from the National Center for Biotechnology Information.
1Preliminary results from this analysis were presented at the International Salmonella and Salmonellosis Symposium, June 6–8, 2016, St. Malo, France, and at the International Association for Food Protection Annual Meeting, July 9–12, 2017, Tampa, Florida, USA.